UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010323
Receipt number R000001616
Scientific Title A study to evaluate the effect of ezetimibe and rosuvastatin on intravascular ultrasound-derived coronary atheroma and lipid lowering effect.
Date of disclosure of the study information 2013/03/27
Last modified on 2017/07/25 13:25:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate the effect of ezetimibe and rosuvastatin on intravascular ultrasound-derived coronary atheroma and lipid lowering effect.

Acronym

Mie study of Ezetimibe and Rosvastatin for attenuation of coronary artery atherosclerosis by using Intravascular ultrasound (MERIT study)

Scientific Title

A study to evaluate the effect of ezetimibe and rosuvastatin on intravascular ultrasound-derived coronary atheroma and lipid lowering effect.

Scientific Title:Acronym

Mie study of Ezetimibe and Rosvastatin for attenuation of coronary artery atherosclerosis by using Intravascular ultrasound (MERIT study)

Region

Japan


Condition

Condition

dyslipidemia

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Compare of the coronary artery plaque volume between statin only and statin eith ezetimibe by intravascular-ultrasound.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The change in coronary atheroma by serial volumetoric intravascular-ultrasound analysis

Key secondary outcomes

body mass index, serum LDL-C, HDL-C, TG, non-HDL, small dense LDL, hs-CRP, HOMA-IR, oxidized LDL and hs-CRP


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

statin only arm

Interventions/Control_2

statin with ezetimibe arm

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

men and women abobe 20 years of age and LDL-chol moreover 100mg/dl with a clinical indication for coronary catheterization therapy and provided written informed consent

Key exclusion criteria

1, privious allergy for ezetimibe or any of statins
2, contraindication for rosuvastatin and already recieved rosuvastatin
3, secondary dyslipidemia
4, history of acute coronary syndrome within 3months before study entry
5, congestive heart failure (NYHA 3 or 4)
6, low left ventricular contractility
7, inducation for coronary artery bypass graft
8, poor control HTN patient (systolic BP over 220mmHg, diastolic BP over 110mmHg)
9, poor control diabetic patient (HbA1c over 9.5%)
10, hemodialysis patient
11, severe renal dysfunction (30 over CCr or serum Cre over 2.0)
12, serum CK over 300
13, severe liver dysfunction

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mashio Nakamura

Organization

Mie University Graduate School of Medicine

Division name

Department of Cardiovascular Research

Zip code


Address

2-174 Edibashi, Tsu, Mie

TEL

059-231-5015

Email

mashio@clin.medic.mie-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Jun Masuda

Organization

Mie University Graduate School of Medicine

Division name

Department of Cardiology and Nephrology

Zip code


Address

2-174 Edibashi, Tsu, Mie

TEL

059-231-5015

Homepage URL


Email

jun-m@clin.medic.mie-u.ac.jp


Sponsor or person

Institute

Department of Cardiology and Nephrology, Mie University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiology and Nephrology, Mie University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Clinical Research Support Center, Mie University Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

三重大学医学部附属病院(三重県)
Mie University Hospital (Mie)


Other administrative information

Date of disclosure of the study information

2013 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/ihj/56/3/56_14-311/_pdf

Number of participants that the trial has enrolled


Results

Intensive lipid-lowering therapy with ezetimibe provide greater reduction in the percent change in plaque volume (PV), the primary endpoint, than the statin monotherapy group (-13.2% versus -3.1%, respectively, P = 0.050).Moreover, percent change in PV showed positive correlations with percent change of LDL-C (r = 0.384, P = 0.015). Intensive lipid-lowering therapy with ezetimibe added to usual-dose statin may provide significant incremental reduction in coronary plaques compared with usual-dose statin monotherapy.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2008 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 10 Month 01 Day

Last follow-up date

2013 Year 04 Month 05 Day

Date of closure to data entry

2013 Year 04 Month 11 Day

Date trial data considered complete

2013 Year 05 Month 27 Day

Date analysis concluded

2013 Year 11 Month 06 Day


Other

Other related information



Management information

Registered date

2013 Year 03 Month 27 Day

Last modified on

2017 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001616


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name